Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29229594

Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2018 Mar 15
First author
Herrera AF

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2018 Mar 15;131(11):1156-1157. doi: 10.1182/blood-2017-12-824136.
    note
    Source null
    related pmid
    29545402
    relationship
    Comment in

Authors and identifiers

  1. name
    Herrera AF
    type
    Author
  2. name
    Moskowitz AJ
    type
    Author
  3. name
    Bartlett NL
    type
    Author
  4. name
    Vose JM
    type
    Author
  5. name
    Ramchandren R
    type
    Author
  6. name
    Feldman TA
    type
    Author
  7. name
    LaCasce AS
    type
    Author
  8. name
    Ansell SM
    type
    Author
  9. name
    Moskowitz CH
    type
    Author
  10. name
    Fenton K
    type
    Author
  11. name
    Ogden CA
    type
    Author
  12. name
    Taft D
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Herrera AF
    type
    Author
  2. name
    Moskowitz AJ
    type
    Author
  3. name
    Bartlett NL
    type
    Author
  4. name
    Vose JM
    type
    Author
  5. name
    Ramchandren R
    type
    Author
  6. name
    Feldman TA
    type
    Author
  7. name
    LaCasce AS
    type
    Author
  8. name
    Ansell SM
    type
    Author
  9. name
    Moskowitz CH
    type
    Author
  10. name
    Fenton K
    type
    Author
  11. name
    Ogden CA
    type
    Author
  12. name
    Taft D
    type
    Author
bibliography ids
  1. nci-bib-5dd9a4c2682d0a012d900929
book metadata
content sha256
5eb3a76fd3badeaad6c6a2fd129477a21c46e1e86fb84490bc5e2bccff0da953
document type
citation
dois
  1. 10.1182/blood-2017-10-811224
electronic publication date
display
2017 Dec 11
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:29229594
immutable id
pubmed:29229594@5eb3a76fd3badeaad6c6a2fd129477a21c46e1e86fb84490bc5e2bccff0da953
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
11
name
Blood
nlm unique id
7603509
pages
1183-1194
volume
131
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2018 Mar 15;131(11):1156-1157. doi: 10.1182/blood-2017-12-824136.
    note
    Source null
    related pmid
    29545402
    relationship
    Comment in
outcomes validated
false
pmid
29229594
provenance
batch id
ec9444d0f4cade22eb9f
provider
NCBI PubMed ESummary
record sha256
a27facf88493c6870cb1b9c5905d885dcc10ef7b9c1246bafef110726ddd6f33
response sha256
6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
retrieved at
2026-09-09T23:47:30.975610+00:00
publication date
display
2018 Mar 15
precision
day
year
2018
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Multicenter Study
  5. Research Support, N.I.H., Extramural
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29229594/
title
Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma.

Preserved source evidence · Not medical advice